TY - CHAP
T1 - Embryonic stem cells, nuclear transfer and parthenogenesis-derived stem cells for urological reconstruction
AU - Dorin, Ryan
AU - Yamzon, Jonathan
AU - Koh, Chester J.
PY - 2009/1/1
Y1 - 2009/1/1
N2 - Regenerative medicine has made substantial progress in addressing congenital and acquired diseases that result in end organ failure by combining the principles of cell biology, materials science, engineering, and transplantation. This chapter will discuss the basic principles of tissue engineering and the contemporary use of stem cells in the field of urological research. It will also provide a review of leading stem cell procurement techniques utilized in contemporary tissue engineering labs. These include embryonic stem cell harvest, parthenogenesis, nuclear transfer, and most recently, induced pluripotent stem cells.
AB - Regenerative medicine has made substantial progress in addressing congenital and acquired diseases that result in end organ failure by combining the principles of cell biology, materials science, engineering, and transplantation. This chapter will discuss the basic principles of tissue engineering and the contemporary use of stem cells in the field of urological research. It will also provide a review of leading stem cell procurement techniques utilized in contemporary tissue engineering labs. These include embryonic stem cell harvest, parthenogenesis, nuclear transfer, and most recently, induced pluripotent stem cells.
UR - http://www.scopus.com/inward/record.url?scp=84902392446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902392446&partnerID=8YFLogxK
U2 - 10.1533/9781845696375.3.357
DO - 10.1533/9781845696375.3.357
M3 - Chapter
AN - SCOPUS:84902392446
SN - 9781845694029
SP - 357
EP - 377
BT - Biomaterials and Tissue Engineering in Urology
PB - Elsevier
ER -